Northwest Eye surgeons

Blog

OUR FOCUS IS YOUR VISION

Simplifying the IOL Menu

In-N-Out Burger is a fast-food restaurant chain that was founded in Southern California in 1948–seven years before McDonald’s was founded in the same region. In-N-Out is unique among large American fare fast-food chains, not necessarily because of its quality (though I am definitely a fan), but because of the simplicity of its menu. The menu… Read More


A Review of Corneal Edema in the Ocular Hypertensive Patient

A Review of Corneal Edema in the Ocular Hypertensive Patient

The cornea is an avascular tissue, which relies on the atmosphere for the majority of its oxygen requirements and the aqueous humor for most of its other nutritional needs.  The dehydrated state of the cornea is what allows for corneal transparency. When this dehydrated state is compromised, the result is corneal edema.  The main factors… Read More


Pain without Stain

Pain without Stain

The Elusive Neurotrophic Keratitis The cornea is the first line of defense of the eye, and as such is the most densely innervated and sensitive tissue in the body. With a central corneal nerve density of approximately 7,000 nociceptors per square millimeter the cornea is 300 to 600 times more sensitive than skin.1 These nerves play a vital… Read More


Neovascular AMD Management:  What’s on the Horizon?

Neovascular AMD Management: What’s on the Horizon?

It was January 15th, 2005 when the FDA approved Macugen, the first anti-VEGF treatment for neovascular AMD (nAMD).  Within 6 months, Phil Rosenfeld, MD, out of Bascom Palmer Eye Institute, published the first paper touting the efficacy of Avastin.1  Lucentis and Eylea became commercially available within the next 5 years, and treatment paradigms have witnessed… Read More


Northwest Eye Clinical Research Update: The Glaukos iDose GC-012 Study

Northwest Eye Clinical Research Update: The Glaukos iDose GC-012 Study

  Study Overview Northwest Eye Surgeons is happy to announce that Drs. Cameron and Kuzin are Principal Investigators in an active FDA approved Phase III clinical study on iDose Travoprost Intraocular Implants.  This is a prospective, randomized masked three year study comparing novel implantable glaucoma medication delivery devices to topical timolol.  One of two biocompatible… Read More


Post-Operative Hyphema

Post-Operative Hyphema

With the widespread adoption of clear corneal incisions during routine cataract surgery, little post-operative bleeding is expected during follow-up.  However, when hyphema or bleeding into the anterior chamber is seen post-operatively it must be managed appropriately to minimize morbidity and promote visual recovery.  The following article summarizes the causes of post-operative hyphema, suggests an approach… Read More


Angle Closure

Angle Closure

According to the World Health Organization, glaucoma is the leading cause of preventable blindness worldwide. Glaucoma can be subdivided into two types based on anterior segment anatomy: open-angle glaucoma or angle-closure glaucoma. While open-angle glaucoma is the significantly more prevalent form of the two, angle-closure glaucoma is more likely to cause bilateral blindness. Angle closure… Read More


Where to Start with Plaquenil Screenings

Where to Start with Plaquenil Screenings

Plaquenil (hydroxychloroquine) has been thrusted into the spotlight due to the current COVID-19 pandemic. Its off-label use has been used a potential therapy for the virus, all data being anecdotal at best. Before COVID-19, Plaquenil was first used as an anti-malarial, but quickly started being used for a myriad of autoimmune diseases. The anti-inflammatory effects… Read More


A Rare Case of Nevus of Ota 

A Rare Case of Nevus of Ota 

Paul Krabill, OD, partnered in authoring the article “A Rare Case of Nevus of Ota,” in the current issue of the Review of Optometry. The article “reviews a Caucasian patient with primary choroidal melanoma presented with a surprising underlying diagnosis.” This was a case report submitted through the Larry Alexander Case Report contest sponsored by the Optometric Retina… Read More


Evolution of Corneal Transplants

Evolution of Corneal Transplants

  In 1904 Edward Zirm performed the first successful full thickness corneal transplant in a person. It is reported that the person went on to see well enough to work for a number of months after his surgery.  For about 100 years we have performed penetrating keratoplasty and restoring patients’ vision.  Everyone would like to… Read More


Hear From Our Patients